Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C13H13IN2O2 |
| Molecular Weight | 356.159 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)C1=CN=CN1[C@H](C)C2=CC=C(I)C=C2
InChI
InChIKey=KECBLXVYTIVCTG-SECBINFHSA-N
InChI=1S/C13H13IN2O2/c1-9(10-3-5-11(14)6-4-10)16-8-15-7-12(16)13(17)18-2/h3-9H,1-2H3/t9-/m1/s1
| Molecular Formula | C13H13IN2O2 |
| Molecular Weight | 356.159 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Iodometomidate I-123, R- (also known as ) is phenylethylimidazole derivative studied as a diagnostic agent for adrenal imaging. Iodometomidate is a highly suitable tracer combining specific uptake in adrenocortical tissue with far lower radiation exposure compared to norcholesterol scintigraphy. Phase III clinical trial for Adrenal Gland Neoplasms imaging is currently ongoing.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:53:37 GMT 2025
by
admin
on
Mon Mar 31 17:53:37 GMT 2025
|
| Record UNII |
U21CVV13SV
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID50231064
Created by
admin on Mon Mar 31 17:53:37 GMT 2025 , Edited by admin on Mon Mar 31 17:53:37 GMT 2025
|
PRIMARY | |||
|
U21CVV13SV
Created by
admin on Mon Mar 31 17:53:37 GMT 2025 , Edited by admin on Mon Mar 31 17:53:37 GMT 2025
|
PRIMARY | |||
|
11660398
Created by
admin on Mon Mar 31 17:53:37 GMT 2025 , Edited by admin on Mon Mar 31 17:53:37 GMT 2025
|
PRIMARY | |||
|
813466-05-6
Created by
admin on Mon Mar 31 17:53:37 GMT 2025 , Edited by admin on Mon Mar 31 17:53:37 GMT 2025
|
PRIMARY | |||
|
DB13021
Created by
admin on Mon Mar 31 17:53:37 GMT 2025 , Edited by admin on Mon Mar 31 17:53:37 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET->RADIOLIGAND |
No selectivity for CYP11B2 over CYP11B1.
IC50
|
||
|
|
TARGET->RADIOLIGAND |
No selectivity for CYP11B2 over CYP11B1.
IC50
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
